Key result
Estrogen attenuates stress-induced cardiomyopathy by preserving β2-adrenergic receptors and promoting anti-inflammatory macrophages.
Why the study?
Postmenopausal women are predisposed to chronic stress-induced cardiomyopathy, and researchers sought to determine whether estrogen modulates the macrophage β2AR-Gs/Gi pathway to confer cardioprotection during stress.
Population
Female Sprague-Dawley rats and peritoneal macrophages from wild-type and β2AR-knockout female mice
Comparison
Estradiol vs vehicle or β2AR blocker under isoproterenol stress after ovariectomy or sham surgery
Design
Preclinical in vivo and in vitro experimental study
Authors
Loading...
Hypothesis-generating for estrogen in stress cardiomyopathy; leaves open human translation pending clinical trials.
Estrogen confers cardioprotection against chronic stress-induced cardiomyopathy by promoting adaptive immunomodulation of macrophage phenotypes via β2-adrenergic receptor-mediated signaling.
Hou et al. (2021) studied Chronic stress-induced cardiomyopathy. Estradiol (E2) vs. Placebo (olive oil) / Ovariectomy without E2 was evaluated on Macrophage polarization and cardiac function. Estrogen attenuated chronic stress-induced cardiomyopathy by preventing excessive depletion of β2-adrenergic receptors and enhancing the polarization of macrophages from a pro-inflammatory CD86+ to an anti-inflammatory CD206+ phenotype.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: